Literature DB >> 17581828

Elevated endothelial microparticles in Fabry children decreased after enzyme replacement therapy.

Monique P Gelderman, Raphael Schiffmann, Jan Simak.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17581828     DOI： 10.1161/ATVBAHA.107.143511

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN： 1079-5642            Impact factor:   8.311


× No keyword cloud information.
  10 in total

1.  α-galactosidase A deficiency promotes von Willebrand factor secretion in models of Fabry disease.

Authors:  Justin J Kang; Nayiri M Kaissarian; Karl C Desch; Robert J Kelly; Liming Shu; Peter F Bodary; James A Shayman
Journal:  Kidney Int       Date:  2018-11-22       Impact factor: 10.612

Review 2.  Can we use statins to prevent stroke in Fabry disease?

Authors:  J M Politei
Journal:  J Inherit Metab Dis       Date:  2009-06-02       Impact factor: 4.982

3.  Globotriaosylceramide induces oxidative stress and up-regulates cell adhesion molecule expression in Fabry disease endothelial cells.

Authors:  Jin-Song Shen; Xing-Li Meng; David F Moore; Jane M Quirk; James A Shayman; Raphael Schiffmann; Christine R Kaneski
Journal:  Mol Genet Metab       Date:  2008-08-15       Impact factor: 4.797

4.  Mannose 6-phosphate receptor and sortilin mediated endocytosis of α-galactosidase A in kidney endothelial cells.

Authors:  Thaneas Prabakaran; Rikke Nielsen; Simon C Satchell; Peter W Mathieson; Ulla Feldt-Rasmussen; Søren S Sørensen; Erik I Christensen
Journal:  PLoS One       Date:  2012-06-29       Impact factor: 3.240

Review 5.  Recommendations for the diagnosis and management of Fabry disease in pediatric patients: a document from the Rare Diseases Committee of the Brazilian Society of Nephrology (Comdora-SBN).

Authors:  Maria Helena Vaisbich; Luís Gustavo Modelli de Andrade; Cassiano Augusto Braga Silva; Fellype de Carvalho Barreto
Journal:  J Bras Nefrol       Date:  2022 Apr-Jun

6.  Cerebral hemodynamics and endothelial function in patients with Fabry disease.

Authors:  Tomás Segura; Oscar Ayo-Martín; Isabel Gómez-Fernandez; Carolina Andrés; Miguel A Barba; José Vivancos
Journal:  BMC Neurol       Date:  2013-11-11       Impact factor: 2.474

7.  Cryptogenic stroke and small fiber neuropathy of unknown etiology in patients with alpha-galactosidase A -10T genotype.

Authors:  Michael Schelleckes; Malte Lenders; Katrin Guske; Boris Schmitz; Christian Tanislav; Sonja Ständer; Dieter Metze; Istvan Katona; Joachim Weis; Stefan-Martin Brand; Thomas Duning; Eva Brand
Journal:  Orphanet J Rare Dis       Date:  2014-11-26       Impact factor: 4.123

8.  A pilot study of circulating microRNAs as potential biomarkers of Fabry disease.

Authors:  Giuseppe Cammarata; Simone Scalia; Paolo Colomba; Carmela Zizzo; Antonio Pisani; Eleonora Riccio; Michaela Montalbano; Riccardo Alessandro; Antonello Giordano; Giovanni Duro
Journal:  Oncotarget       Date:  2018-06-08

9.  Abnormal nonstoring capillary endothelium: a novel feature of Gaucher disease. Ultrastructural study of dermal capillaries.

Authors:  Helena Hůlková; Helena Poupetová; Klaus Harzer; Pramod Mistry; Johannes M F G Aerts; Milan Elleder
Journal:  J Inherit Metab Dis       Date:  2010-01-05       Impact factor: 4.982

10.  Clinical CVVH model removes endothelium-derived microparticles from circulation.

Authors:  Abdelhafeez H Abdelhafeez; Paul M Jeziorczak; Terry R Schaid; Susan L Hoefs; Sushma Kaul; Rahul Nanchal; Elizabeth R Jacobs; John C Densmore
Journal:  J Extracell Vesicles       Date:  2014-02-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.